BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31301235)

  • 21. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia.
    Ferreira JJ; Colosimo C; Bhidayasiri R; Marti MJ; Maisonobe P; Om S
    Parkinsonism Relat Disord; 2015 Feb; 21(2):111-5. PubMed ID: 25499753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal assessment of the dose consistency of botulinum toxin type A (BOTOX) for cervical dystonia.
    Brashear A; Hogan P; Wooten-Watts M; Marchetti A; Magar R; Martin J
    Adv Ther; 2005; 22(1):49-55. PubMed ID: 15943222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey.
    Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; De Oliveira CQ; Verhagen AP
    J Neural Transm (Vienna); 2024 Jan; 131(1):43-51. PubMed ID: 37831150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for botulinum neurotoxin injections in piriformis syndrome.
    Yi KH; Lee KL; Lee JH; Hu HW; Lee K; Seo KK; Kim HJ
    Clin Anat; 2021 Oct; 34(7):1028-1034. PubMed ID: 33347678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accessory nerve distribution for aesthetic botulinum toxin injections into the upper trapezius muscle: anatomical study and clinical trial : Reproducible BoNT injection sites for upper trapezius.
    Bae JH; Lee JS; Choi DY; Suhk J; Kim ST
    Surg Radiol Anat; 2018 Nov; 40(11):1253-1259. PubMed ID: 29946827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections.
    Häkkinen A; Ylinen J; Rinta-Keturi M; Talvitie U; Kautiainen H; Rissanen A
    Arch Phys Med Rehabil; 2004 Oct; 85(10):1684-8. PubMed ID: 15468031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
    Marsili L; Bologna M; Jankovic J; Colosimo C
    Expert Opin Drug Saf; 2021 Jun; 20(6):695-705. PubMed ID: 33831328
    [No Abstract]   [Full Text] [Related]  

  • 30. Doxorubicin chemomyectomy as a treatment for cervical dystonia: histological assessment after direct injection into the sternocleidomastoid muscle.
    McLoon LK; Falkenberg JH; Dykstra D; Iaizzo PA
    Muscle Nerve; 1998 Nov; 21(11):1457-64. PubMed ID: 9771670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
    Ansved T; Odergren T; Borg K
    Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group.
    Kessler KR; Skutta M; Benecke R
    J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lateral pterygoid muscle dystonia. A new technique for treatment with botulinum toxin guided by electromyography and arthroscopy.
    Martos-Díaz P; Rodríguez-Campo FJ; Bances-del Castillo R; Altura-Guillén O; Cho-Lee GY; Mancha-de la-Plata M; Escorial-Hernandez V
    Med Oral Patol Oral Cir Bucal; 2011 Jan; 16(1):e96-9. PubMed ID: 20711164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative electromyography-guided botulinum toxin treatment of cervical dystonia.
    Finsterer J; Fuchs I; Mamoli B
    Clin Neuropharmacol; 1997 Feb; 20(1):42-8. PubMed ID: 9037572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramuscular Neural Arborization of the Latissimus Dorsi Muscle: Application of Botulinum Neurotoxin Injection in Flap Reconstruction.
    Yi KH; Lee HJ; Seo KK; Kim HJ
    Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
    Yoshida K
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Anterocapitis and Anterocollis: A Novel Ultrasound Guided Approach Combined with Electromyography for Botulinum Toxin Injection of Longus Colli and Longus Capitis.
    Farrell M; Karp BI; Kassavetis P; Berrigan W; Yonter S; Ehrlich D; Alter KE
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33008043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin treatment of dystonic anterocollis: What to inject.
    Marion MH; Hicklin LA
    Parkinsonism Relat Disord; 2021 Jul; 88():34-39. PubMed ID: 34102419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.